| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1111/HEPR.12245 |
| P698 | PubMed publication ID | 25224130 |
| P2093 | author name string | Takashi Wada | |
| Mikio Zeniya | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis | Q28943317 | ||
| Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
| Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis | Q44493764 | ||
| Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial | Q45309693 | ||
| In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset | Q46177088 | ||
| Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. | Q50878460 | ||
| EASL Clinical Practice Guidelines: management of cholestatic liver diseases. | Q55051951 | ||
| P433 | issue | 9 | |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 935-936 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Hepatology Research | Q15752035 |
| P1476 | title | Immunosuppressive therapy for primary biliary cirrhosis: Do we need in future? | |
| P478 | volume | 44 |
Search more.